|
STOK Stoke Therapeutics Inc 1623526 |
| Balance Sheet |
|
Current Assets
|
$322,538,000.00 |
|
Assets
|
$393,966,000.00 |
|
Current Liabilities
|
$41,930,000.00 |
|
Liabilities
|
$48,419,000.00 |
|
Equity
|
$345,547,000.00 |
|
Shares Out
|
62402595.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-117,167,000.00 |
|
Investing Cash Flow
|
$59,712,000.00 |
| Market Analysis |
Market Cap
|
$1,959,441,483.00 |
|
Price
|
$31.40 |
|
BVPS
|
5.54 |
|
PB
|
5.67 |
|
EPS
|
-0.93 |
|
PS
|
52.53 |
|
FCF
|
$-119,496,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:21 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-0.12 |
|
|
2026-05-07 |
-0.79 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.40 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.65 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view STOK documents filed with the SEC.
STOK Filings
Clear
